Aspirin as Thromboprophylaxis in Orthopedic Surgery: A Matter of Perspective
- PMID: 37533788
- PMCID: PMC10393082
- DOI: 10.1097/HS9.0000000000000933
Aspirin as Thromboprophylaxis in Orthopedic Surgery: A Matter of Perspective
Conflict of interest statement
REGS is a Scientific Editor at HemaSphere. SM has received honoraria from Astra Zeneca, Norgine, Alveron, Bayer, Abbvie, Hemab, Viatris, and Sanofi. All fees are directly paid to the hospital.
References
-
- Agarwal AR, Das A, Harris A, et al. . Trends of Venous Thromboembolism After Total Hip Arthroplasty in the United States: Analysis From 2011 to 2019. J Am Acad Orthop Surg. 2023;31:e376–e384. - PubMed
-
- Anderson DR, Dunbar M, Murnaghan J, et al. . Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018;378:699–707. - PubMed
-
- Farey JE, An VVG, Sidhu V, et al. . Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis. Orthop Traumatol Surg Res. 2021;107:102606. - PubMed
Publication types
LinkOut - more resources
Full Text Sources